Current Status of Retroviral Vector Mediated Gene Transfer into Human Hematopoietic Stem Cells

References

• Williams D. A., Lemischka I. R., Nathan D. G., Mulligan R. C. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 1984; 310: 476–480
   PubMed Web of Science ®Google Scholar
• Keller G., Paige C., Gilboa E., Wagner E. F. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature 1985; 318: 149–154
   PubMed Web of Science ®Google Scholar
• Bodine D. M., Moritz T., Donahue R. E., Luskey B. D., Kessler S. W., Martin D. I., Orkin S. H., Nienhuis A. W., Williams D. A. Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into cd34+ bone marrow cells. Blood 1993; 82: 1975–1980
   PubMed Web of Science ®Google Scholar
• Weinberg K. I., Kohn D. B. Gene therapy for congenital lymphoid immunodeficiency diseases. Seminars In Hematology 1998; 35: 354–366
   PubMed Web of Science ®Google Scholar
• Kantoff P. W., Gillio A. P., McLachlin J. R., Bordignon C., Eglitis M. A., Keman N. A., Moen R. C., Kohn D. B., Yu S. F., Karson E. Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. Journal of Experimental Medicine 1987; 166: 219–234
   PubMed Web of Science ®Google Scholar
• Van Beusechem V. W., Kukler A., Bakx T. A., Valerio D. Somatic cell gene therapy: The model of adenosine deaminase deficiency. Bone Marrow Transplantation 1989; 4(Suppl 4)133–136
   PubMedGoogle Scholar
• Hoeben R. C., Valerio D., van der Eb A. J., van Ormondt H. Gene therapy for human inherited disorders: Techniques and status. Critical Reviews In Oncology/Hematology 1992; 13: 33–54
   PubMed Web of Science ®Google Scholar
• van Beusechem V. W., Kukler A., Einerhand M. P., Bakx T. A., van der Eb A. I., van Bekkum D. W., Valerio D. Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses. Journal of Experimental Medicine 1990; 172: 729–736
   PubMed Web of Science ®Google Scholar
• Valerio D., Dekker B. M., Duyvesteyn M. G., van der Voorn L., Berkvens T. M., van Ormondt H., van der Eb A. J. One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity. EMBO Journal 1986; 5: 113–119
   PubMed Web of Science ®Google Scholar
• van Beusechem V. W., Kukler A., Heidt P. J., Valerio D. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 7640–7644
   PubMed Web of Science ®Google Scholar
• Hoogerbrugge P. M., von Beusechem V. W., Kaptein L. C., Einerhand M. P., Valerio D. Gene therapy for adenosine deaminase deficiency. British Medical Bulletin 1995; 51: 72–81
   PubMed Web of Science ®Google Scholar
• Migchielsen A. A., Breuer M. L., Hershfield M. S., Valerio D. Full genetic rescue of adenosine deaminase-deficient mice through introduction of the human gene. Human Molecular Genetics 1996; 5: 1523–1532
   PubMed Web of Science ®Google Scholar
• Kaptein L. C., Einerhand M. P., Braakman E., Valerio D., van Beusechem V. W. Bone marrow gene therapy for adenosine deaminase deficiency. Immunodeficiency 1993; 4: 335–345
   PubMedGoogle Scholar
• Osborne W. R., Hock R. A., Kaleko M., Miller A. D. Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors. Human Gene Therapy 1990; 1: 31–41
   PubMed Web of Science ®Google Scholar
• Dunbar C. E., Kohn D. B., Schiffmann R., Barton N. W., Nolta J. A., Esplin J. A., Pensiero M., Long Z., Lockey C., Emmons R. V., Csik S., Leitman S., Krebs C. B., Carter C., Brady R. O., Karlsson S. Retroviral transfer of the glucocerebrosidase gene into cd34+ cells from patients with gaucher disease: In vivo detection of transduced cells without myeloablation. Human Gene Therapy 1998; 9: 2629–2640
   PubMed Web of Science ®Google Scholar
• Kohn D. B., Nolta J. A., Weinthal J., Banner I., Yu X. J., Lilley J., Crooks G. M. Toward gene therapy for gaucher disease. Human Gene Therapy 1991; 2: 101–105
   PubMed Web of Science ®Google Scholar
• Nolta J. A., Yu X. J., Banner I., Kohn D. B. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured gaucher bone marrow [published erratum appears in j clin invest 1992 oct; 90(4):Following 1634]. Journal Of Clinical Investigation 1992; 90: 342–348
   PubMed Web of Science ®Google Scholar
• Schuening F., Longo W. L., Atkinson M. E., Zaboikin M., Kiem H. P., Sanders J., Scott C. R., Storb R., Miller A. D., Reynolds T., Bensinger W., Rowley S., Gooley T., Darovsky B., Appelbaum F. Retrovirus-mediated transfer of the cdna for human glucocerebrosidase into peripheral blood repopulating cells of patients with gaucher's disease. Human Gene Therapy 1997; 8: 2143–2160
   PubMed Web of Science ®Google Scholar
• Weinthal J., Nolta J. A., Yu X. J., Lilley J., Uribe L., Kohn D. B. Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells. Bone Marrow Transplantation 1991; 8: 403–412
   PubMed Web of Science ®Google Scholar
• Lee T. C., Sullenger B. A., Gallardo H. F., Ungers G. E., Gilboa E. Overexpression of rre-derived sequences inhibits hiv-1 replication in cem cells. New Biol 1992; 4: 66–74
   PubMedGoogle Scholar
• Sullenger B. A., Gallardo H. F., Lingers G. E., Gilboa E. Overexpression of tar sequences renders cells resistant to human immunodeficiency virus replication. Cell 1990; 63: 601–608
   PubMed Web of Science ®Google Scholar
• Dunbar C. E., Cottier-Fox M., O'Shaughnessy J. A., Doren S., Carter C., Berenson R., Brown S., Moen R. C., Greenblatt J., Stewart F. M. Retrovirally marked cd34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048–3057
   PubMed Web of Science ®Google Scholar
• Rill D. R., Moen R. C., Buschle M., Bartholomew C., Foreman N. K., Mirro J. J., Krance R. A., Ihle J. N., Brenner M. K. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood 1992; 79: 2694–2700
   PubMed Web of Science ®Google Scholar
• Brenner M. K., Rill D. R., Holladay M. S., Heslop H. E., Moen R. C., Buschle M., Krance R. A., Santana V. M., Anderson W. F., Ihle J. N. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993; 342: 1134–1137
   PubMed Web of Science ®Google Scholar
• Keller G., Snodgrass R. Life span of multipotential hematopoietic stem cells in vivo. J Exp Med 1990; 171: 1407–1418
   PubMed Web of Science ®Google Scholar
• Blaese R. M., Culver K. W., Miller A. D., Carter C. S., Fleisher T., Clerici M., Shearer G., Chang L., Chiang Y., Tolstoshev P., et al. T lymphocyte-directed gene therapy for ada-scid: Initial trial results after 4 years. Science 1995; 270: 475–480
   PubMed Web of Science ®Google Scholar
• Bordignon C., Notarangelo L. D., Nobili N., Ferrari G., Casorati G., Panina P., Mazzolari E., Maggioni D., Rossi C., Servida P., et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ada-immunodeficient patients. Science 1995; 270: 470–475
   PubMed Web of Science ®Google Scholar
• Kohn D. B., Weinberg K. I., Nolta J. A., Heiss L. N., Lenarsky C., Crooks G. M., Hanley M. E., Annett G., Brooks J. S., el-Khoureiy A., et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Medicine 1995; 1: 1017–1023
   PubMed Web of Science ®Google Scholar
• Hoogerbrugge P. M., van Beusechem V. W., Fischer A., Debree M., le Deist F., Perignon J. L., Morgan G., Gaspar B., Fairbanks L. D., Skeoch C. H., Moseley A., Harvey M., Levinsky R. J., Valerio D. Bone marrow gene transfer in three patients with adenosine deaminase deficiency. Gene Therapy 1996; 3: 179–183
   PubMed Web of Science ®Google Scholar
• Brenner M. K., Rill D. R., Moen R. C., Krance R. A., Mirro J. J., Anderson W. F., Ihle J. N. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85–86
   PubMed Web of Science ®Google Scholar
• Deisseroth A. B., Zu Z., Claxton D., Hanania E. G., Fu S., Ellerson D., Goldberg L., Thomas M., Janicek K., Anderson W. F., et al. Genetic marking shows that ph+ cells present in autologous transplants of chronic myelogenous leukemia (cml) contribute to relapse after autologous bone marrow in cml. Blood 1994; 83: 3068–3076
   PubMed Web of Science ®Google Scholar
• Hanania E. G., Giles R. E., Kavanagh J., Fu S. Q., Ellerson D., Zu Z., Wang T., Su Y., Kudelka A., Rahman Z., Holmes F., Hortobagyi G., Claxton D., Bachier C., Thall P., Cheng S., Hester J., Ostrove J. M., Bird R. E., Chang A., Korbling M., Seong D., Cote R., Holzmayer T., Deisseroth A. B., et al. Results of mdr-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 15346–15351, [published erratum appears in proc natl acad sci u s a 1997 may 13; 94(10):5495]
   PubMed Web of Science ®Google Scholar
• Emmons R. V., Doren S., Zujewski J., Cottier-Fox M., Carter C. S., Hines K., O'Shaughnessy J. A., Leitman S. F., Greenblatt J. J., Cowan K., Dunbar C. E. Retroviral gene transduction of adult peripheral blood or marrow-derived cd34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood 1997; 89: 4040–4046
   PubMed Web of Science ®Google Scholar
• Kiem H. P., Darovsky B., Von Kalle C., Goehle S., Graham T., Miller A. D., Storb R., Schuening F. G. Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors. Human Gene Therapy 1996; 7: 89–96
   PubMed Web of Science ®Google Scholar
• Van Beusechem V. W., Bart-Baumeister J. A., Bakx T. A., Kaptein L. C., Levinsky R. J., Valerio D. Gene transfer into nonhuman primate cd34+cd11b-bone marrow progenitor cells capable of repopulating lymphoid and myeloid lineages. Human Gene Therapy 1994; 5: 295–305
   PubMed Web of Science ®Google Scholar
• Xu L. C., Karlsson S., Byrne E. R., Kluepfel-Stahl S., Kessler S. W., Agricola B. A., Sellers S., Kirby M., Dunbar C. E., Brady R. O., et al. Long-term in vivo expression of the human glucocerebrosidase gene in nonhuman primates after cd34+ hematopoietic cell transduction with cell-free retroviral vector preparations. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 4372–4376
   PubMed Web of Science ®Google Scholar
• Bienzle D., Abrams-Ogg A. C., Kruth S. A., Ackland-Snow J., Carter R. F., Dick J. E., Jacobs R. M., Kamel-Reid S., Dubé I. D. Gene transfer into hematopoietic stem cells: Long-term maintenance of in vitro activated progenitors without marrow ablation. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 350–354
   PubMed Web of Science ®Google Scholar
• Kaptein L. C., Van Beusechem V. W., Rivière I., Mulligan R. C., Valerio D. Long-term in vivo expression of the mfg-ada retroviral vector in rhesus monkeys transplanted with transduced bone marrow cells. Human Gene Therapy 1997; 8: 1605–1610
   PubMed Web of Science ®Google Scholar
• Anderson W. F. Human gene therapy. Science 1992; 256: 808–813
   PubMed Web of Science ®Google Scholar
• Miller A. D. Human gene therapy comes of age. Nature 1992; 357: 455–460
   PubMed Web of Science ®Google Scholar
• Bank A. Human somatic cell gene therapy. BioEssays 1996; 18: 999–1007
   PubMed Web of Science ®Google Scholar
• Romano G., Micheli P., Pacilio C., Giordano A. Latest developments in gene transfer technology: Achievements, perspectives, and controversies over therapeutic applications. Stem Cells 2000; 18: 19–39
   PubMed Web of Science ®Google Scholar
• Donahue R. E., Kessler S. W., Bodine D., McDonagh K., Dunbar C., Goodman S., Agricola B., Byrne E., Raffeld M., Moen R., et al. Helper virus induced t cell lymphoma in nonhuman primates after retroviral mediated gene transfer. Journal of Experimental Medicine 1992; 176: 1125–1135
   PubMed Web of Science ®Google Scholar
• Miller A. D. Retrovirus packaging cells. Human Gene Therapy 1990; 1: 5–14
   PubMed Web of Science ®Google Scholar
• Yang S., Delgado R., King S. R., Woffendin C., Barker C. S., Yang Z. Y., Xu L., Nolan G. P., Nabel G. J. Generation of retroviral vector for clinical studies using transient transfection. Human Gene Therapy 1999; 10: 123–132
   PubMed Web of Science ®Google Scholar
• Orlic D., Girard L. J., Anderson S. M., Do B. K., Seidel N. E., Jordan C. T., Bodine D. M. Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mrna levels. Stem Cells 1997; 15(Suppl 1)23–28, discussion 28–29
   PubMedGoogle Scholar
• Sabatino D. E., Do B. Q., Pyle L. C., Seidel N. E., Girard L. J., Spratt S. K., Orlic D., Bodine D. M. Amphotropic or gibbon ape leukemia virus retrovirus binding and transduction correlates with the level of receptor mrna in human hematopoietic cell lines. Blood Cells, Molecules, And Diseases 1997; 23: 422–433
   PubMed Web of Science ®Google Scholar
• Miller D. G., Adam M. A., Miller A. D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239–4242
   PubMed Web of Science ®Google Scholar
• Sekhar M., Yu J. M., Soma T., Dunbar C. E. Murine long-term repopulating ability is compromised by ex vivo culture in serum-free medium despite preservation of committed progenitors. Journal Of Hematotherapy 1997; 6: 543–549
   PubMedGoogle Scholar
• Challita P. M., Kohn D. B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 2567–2571
   PubMed Web of Science ®Google Scholar
• Leboulch P., Huang G. M., Humphries R. K., Oh Y. H., Eaves C. J., Tuan D. Y., London I. M. Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure. Embo Journal 1994; 13: 3065–3076
   PubMed Web of Science ®Google Scholar
• Riddell S. R., Elliott M., Lewinsohn D. A., Gilbert M. J., Wilson L., Manley S. A., Lupton S. D., Overall R. W., Reynolds T. C., Corey L., Greenberg P. D. T-cell mediated rejection of gene-modified hiv-specific cytotoxic t lymphocytes in hiv-infected patients. Nature Medicine 1996; 2: 216–223
   PubMed Web of Science ®Google Scholar
• von Kalle C., Kiem H. P., Goehle S., Darovsky B., Heimfeld S., Torok-Storb B., Storb R., Schuening F. G. Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudo-typed retroviral vector. Blood 1994; 84: 2890–2897
   PubMed Web of Science ®Google Scholar
• Kiem H. P., Heyward S., Winkler A., Potter J., Allen J. M., Miller A. D., Andrews R. G. Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 1997; 90: 4638–4645
   PubMed Web of Science ®Google Scholar
• Glimm H., Kiem H. P., Darovsky B., Storb R., Wolf J., Diehl V., Mertelsmann R., Von Kalle C. Efficient gene transfer in primitive cd34+/cd381o human bone marrow cells reselected after long-term exposure to galv-pseudotyped retroviral vector. Human Gene Therapy 1997; 8: 2079–2086
   PubMed Web of Science ®Google Scholar
• Bunnell B. A., Kluge K. A., Lee-Lin S. Q., Byrne E. R., Orlic D., Metzger M. E., Agricola B. A., Wersto R. P., Bodine D. M., Morgan R. A., Donahue R. E. Transplantation of transduced nonhuman primate cd34+ cells using a gibbon ape leukemia virus vector: Restricted expression of the gibbon ape leukemia virus receptor to a subset of cd34+ cells. Gene Therapy 1999; 6: 48–56
   PubMed Web of Science ®Google Scholar
• Bunnell B. A., Metzger M., Byrne E., Morgan R. A., Donahue R. E. Efficient in vivo marking of primary cd4+ t lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 1997; 89: 1987–1995
   PubMed Web of Science ®Google Scholar
• Kiem H. P., Andrews R. G., Morris J., Peterson L., Heyward S., Allen J. M., Rasko J. E., Potter J., Miller A. D. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment ch-296 in combination with interleukin-6, stem cell factor, flt-3 ligand, and megakaryocyte growth and development factor. Blood 1998; 92: 1878–1886
   PubMed Web of Science ®Google Scholar
• Robbins P. B., Yu X. J., Skelton D. M., Pepper K. A., Wasserman R. M., Zhu L., Kohn D. B. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. Journal of Virology 1997; 71: 9466–9474
   PubMed Web of Science ®Google Scholar
• Howrey R. P., El-Alfondi N., Phillips K. L., Wilson L., Rooney B., Lan N., Sullenger B., Smith C. An in-vitro system for efficienctly evaluation gene therapy approaches to hemoglobinopathies. Gene Therapy 2000; 7: 215–220
   PubMed Web of Science ®Google Scholar
• Krall W. J., Skelton D. C., Yu X. J., Riviere I., Lehn P., Mulligan R. C., Kohn D. B. Increased levels of spliced rna account for augmented expression from the mfg retroviral vector in hematopoietic cells. Gene Therapy 1996; 3: 37–48
   PubMed Web of Science ®Google Scholar
• Lee N., Howrey R., Lee S., Smith C., Sullenger B. Trans-splicing mediated repair of hemoglobins to hemoglobina. Science 1998; 280: 1593–1596
   PubMed Web of Science ®Google Scholar
• Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see comments]. Science 1996; 272: 263–267
   PubMed Web of Science ®Google Scholar
• Kafri T., Blomer U., Peterson D. A., Gage F. H., Verma I. M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genetics 1997; 17: 314–317
   PubMed Web of Science ®Google Scholar
• Klimatcheva E., Rosenblatt J. D., Planelles V. Lentiviral vectors and gene therapy, [review] [149 refs]. Frontiers in Bioscience 1999; 4: D481–496
   PubMedGoogle Scholar
• Bukrinsky M. I., Haggerty S., Dempsey M. P., Sharova N. A.A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal within hiv-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365: 666–670
   PubMed Web of Science ®Google Scholar
• Dull T., Zufferey R., Kelly M., Mandel R. J., Nguyen M., Trono D., Naldini L. A third-generation lentivirus vector with a conditional packaging system. Journal of Virology 1998; 72: 8463–8471
   PubMed Web of Science ®Google Scholar
• Kafri T., van Praag H., Ouyang L., Gage F. H., Verma I. M. A packaging cell line for lentivirus vectors. Journal of Virology 1999; 73: 576–584
   PubMed Web of Science ®Google Scholar
• Poeschla E. M., Wong-Staal F., Looney D. J. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nature Medicine 1998; 4: 354–357
   PubMed Web of Science ®Google Scholar
• Zufferey R., Dull T., Mandel R. J., Bukovsky A., Quiroz D., Naldini L., Trono D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. Journal of Virology 1998; 72: 9873–9880
   PubMed Web of Science ®Google Scholar
• Case S. S., Price M. A., Jordan C. T., Yu X. J., Wang L., Bauer G., Haas D. L., Xu D., Stripecke R., Naldini L., Kohn D. B., Crooks G. M. Stable transduction of quiescent cd34(+)cd38(-) human hematopoietic cells by hiv-1-based lentiviral vectors. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 2988–2993
   PubMed Web of Science ®Google Scholar
• Evans J. T., Kelly P. F., O'Neill E., Garcia J. V. Human cord blood cd34+cd38-cell transduction via lentivirus-based gene transfer vectors. Human Gene Therapy 1999; 10: 1479–1489
   PubMed Web of Science ®Google Scholar
• Sutton R., Reitsma M., Uchida N., Brown P. Transduction of human progenitor hematopoietic stem cells by hiv-1 based vectors is cell cycle dependent. J of Virol 1999; 73: 3649–3660
   PubMed Web of Science ®Google Scholar
• Nathwani A., Hanawa H., Vandergriff J., Kelly P. F., Vanin E., Nienhuis A. Efficient gene transfer into human cord cd34+ cells and the cd34+cd38-subset using highly purified aav vector preparations that are free of helper virus and wild type aav. Gene Ther 2000; 7: 183–195
   PubMed Web of Science ®Google Scholar
• Frey B., Hackett N., Begelson J., Finberg R., Crystal R., Moore M., Rafii S. High efficiency gene transfer into ex-vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. Blood 1998; 91: 2781–2792
   PubMed Web of Science ®Google Scholar
• Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 1989; 339: 27–30
   PubMed Web of Science ®Google Scholar
• Ogawa M. Differentiation and proliferation of hematopoietic stem cellls. Blood 1993; 81: 2844–2853
   PubMed Web of Science ®Google Scholar
• Nash R., Storb R., Neiman P. Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Blood 1988; 72: 2031–2037
   PubMed Web of Science ®Google Scholar
• Metcalf D. Clonal culture of hemopoietic cells: Techniques and applications. Elsevier, Amsterdam 1984
   Google Scholar
• Petzer A. L., Hogge D. E., Landsdorp P. M., Reid D. S., Eaves C. J. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 1470–1474
   PubMed Web of Science ®Google Scholar
• Audet J., Zandstra P. W., Eaves C. J., Piret J. M. Advances in hematopoietic stem cell culture. Current Opinion In Biotechnology 1998; 9: 146–151
   PubMed Web of Science ®Google Scholar
• Eaves C. J., Sutherland H. J., Udomsakdi C., Lansdorp P. M., Szilvassy S. J., Fraser C. C., Humphries R. K., Barnett M. J., Phillips G. L., Eaves A. C. The human hematopoietic stem cell in vitro and in vivo [see comments]. Blood Cells 1992; 18: 301–307
   PubMedGoogle Scholar
• Sutherland H. J., Eaves C. J., Lansdorp P. M., Thacker J. D., Hogge D. E. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 1991; 78: 666–672
   PubMed Web of Science ®Google Scholar
• Hao Q. L., Thiemann F. T., Petersen D., Smogorzewska E. M., Crooks G. M. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 1996; 88: 3306–3313
   PubMed Web of Science ®Google Scholar
• Barcena A., Muench M., Galy A., Cupp J., Roncarolo M. G., Phillips J., Spits H. Phenotypic and functional analysis of t-cell precursors in the human fetal liver and thymus: Cd7 expression in the early stages of t-and myeloid-cell development. Blood 1993; 82: 3401–3414
   PubMed Web of Science ®Google Scholar
• Miller J., Alley K., McGlave P. Differentiation of natural killer (nk) cells from human primitive marrow progenitors in a stroma-based long-term culture system: Identification of a cd34+7++ nk progenitor. Blood 1994; 83: 2594–2601
   PubMed Web of Science ®Google Scholar
• Miller J. S., McCullar V., Punzel M., Lemischka I. R., Moore K. A. Single adult human cd34(+)/lin-/cd38(-) progenitors give rise to natural killer cells, b-lineage cells, dendritic cells, and myeloid cells. Blood 1999; 93: 96–106
   PubMed Web of Science ®Google Scholar
• Dick J. E., Bhatia M., Gan O., Kapp U., Wang J. C. Assay of human stem cells by repopulation of nod/scid mice. Stem Cells 1997; 15(Suppl 1)199–203, discussion 204–197
   PubMed Web of Science ®Google Scholar
• Larochelle A., Vormoor H., Hanenberg J., Wang M., Bhatia T., Lapidot T., Moritz B., Murdoch L., Xiao I. Identification of primitive hematopoietic cells capable of repopulating nod/scid mice; implications for gene therapy. Nature Medicine 1996; 2: 1329–1337
   PubMed Web of Science ®Google Scholar
• Larochelle A., Vormoor J., Hanenberg H., Wang J. C., Bhatia M., Lapidot T., Moritz T., Murdoch B., Xiao X. L., Kato I., Williams D. A., Dick J. E. Identification of primitive human hematopoietic cells capable of repopulating nod/scid mouse bone marrow: Implications for gene therapy. Nature Medicine 1996; 2: 1329–1337
   PubMed Web of Science ®Google Scholar
• Bhatia M., Bonnet D., Kapp U., Wang J. C., Murdoch B., Dick J. E. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. Journal of Experimental Medicine 1997; 186: 619–624
   PubMed Web of Science ®Google Scholar
• Conneally E., Cashman J., Petzer A., Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 9836–9841
   PubMed Web of Science ®Google Scholar
• Conneally E., Eaves C. J., Humphries R. K. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 1998; 91: 3487–3493
   PubMed Web of Science ®Google Scholar
• Hennemann B., Conneally E., Pawliuk R., Leboulch P., Rose-John S., Reid D., Chuo J. Y., Humphries R. K., Eaves C. J. Optimization of retroviral-mediated gene transfer to human nod/scid mouse repopulating cord blood cells through a systematic analysis of protocol variables. Experimental Hematology 1999; 27: 817–825
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Smith K. A., Mosier D. E., Verma I. M., Torbett B. E. Transduction of human cd34+ cells that mediate long-term engraftment of nod/scid mice by hiv vectors. Science 1999; 283: 682–686
   PubMed Web of Science ®Google Scholar
• Ramirez M., Tottman G., Shultz L., Civin C. I. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. Exp Hem 1998; 26: 332–344
   PubMed Web of Science ®Google Scholar
• Dunbar C. E., Tisdale J., Yu J. M., Soma T., Zujewski J., Bodine D., Sellers S., Cowan K., Donahue R., Emmons R. Transduction of hematopoietic stem cells in humans and in nonhuman primates. Stem Cells 1997; 15(Suppl 1)135–139, discussion 139–140
   PubMedGoogle Scholar
• Dunbar C. E., Seidel N. E., Doren S., Sellers S., Cline A. P., Metzger M. E., Agricola B. A., Donahue R. E., Bodine D. M. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 11871–11876
   PubMed Web of Science ®Google Scholar
• Whitwam T., Haskins M. E., Henthorn P. S., Kraszewski J. N., Kleiman S. E., Seidel N. E., Bodine D. M., Puck J. M. Retroviral marking of canine bone marrow: Long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes. Blood 1998; 92: 1565–1575
   PubMed Web of Science ®Google Scholar
• Donahue R. E., Byrne E. R., Thomas T. E., Kirby M. R., Agricola B. A., Sellers S. E., Gaudernack G., Karisson S., Lansdorp P. M. Transplantation and gene transfer of the human glucocerebrosidase gene into immunoselected primate cd34+thy-1+ cells. Blood 1996; 88: 4166–4172
   PubMed Web of Science ®Google Scholar
• Bernstein J., Boyle D. W., Srour E. F., Cooper R., Jacobs C., Freie B., Liechty E., Clapp D. W. Variation in long-term engraftment of a large consecutive series of lambs transplanted in utero with human hematopoietic cells. Biology Of Blood And Marrow Transplantation 1997; 3: 247–254
   PubMedGoogle Scholar
• Kiem H. P., Darovsky B., von Kalle C., Goehle S., Stewart D., Graham T., Hackman R., Appelbaum F. R., Deeg H. J., Miller A. D., et al. Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells. Blood 1994; 83: 1467–1473
   PubMed Web of Science ®Google Scholar
• Eglitis M. A., Kantoff P. W., McLachlin J. R., Gillio A., Flake A. W., Bordignon C., Moen R. C., Karson E. M., Zwiebel J. A., Kohn D. B., et al. Gene therapy: Efforts at developing large animal models for autologous bone marrow transplant and gene transfer with retroviral vectors. Ciba Foundation Symposium 1987; 130: 229–246
   PubMedGoogle Scholar
• Van Beusechem V. W., Bakx T. A., Kaptein L. C., Bart-Baumeister J. A., Kukler A., Braakman E., Valerio D. Retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells: The effect of viral titers on transduction efficiency. Human Gene Therapy 1993; 4: 239–247
   PubMed Web of Science ®Google Scholar
• Carter R. F., Abrams-Ogg A. C., Dick J. E., Kruth S. A., Valli V. E., Kamel-Reid S., Dubé I. D. Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 1992; 79: 356–364
   PubMed Web of Science ®Google Scholar
• Schuening F., Storb R., Nash R., Stead R. B., Kwok W. W., Miller A. D. Retroviral transfer of genes into canine hematopoietic progenitor cells. Advances In Experimental Medicine And Biology 1988; 241: 9–18
   PubMedGoogle Scholar
• Huhn R. D., Tisdale J. F., Agricola B., Metzger M. E., Donahue R. E., Dunbar C. E. Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning. Human Gene Therapy 1999; 10: 1783–1790
   PubMed Web of Science ®Google Scholar
• Rosenzweig M., MacVittie T. J., Harper D., Hempel D., Glickman R. L., Johnson R. P., Farese A. M., Whiting-Theobald N., Linton G. F., Yamasaki G., Jordon C. T., Malech H. L. Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood 1999; 94: 2271–2286
   PubMed Web of Science ®Google Scholar
• Civin C. I., Strauss L. C., Brovall C., Fackler M. J., Schwartz J. F., Shaper J. H. Antigenic analysis of hematopoiesis. Iii. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against kg-la cells. Journal Of Immunology 1984; 133: 157–165
   PubMed Web of Science ®Google Scholar
• Krause D. S., Fackler M. J., Civin C. I., May W. S. Cd34: Structure, biology, and clinical utility [see comments]. Blood 1996; 87: 1–13
   PubMed Web of Science ®Google Scholar
• Baurn C. M., Weissman I. L., Tsukamoto A. S., Buckle A. M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 2804–2808
   PubMed Web of Science ®Google Scholar
• Andrews R. G., Bryant E. M., Bartelmez S. H., Muirhead D. Y., Knitter G. H., Bensinger W., Strong D. M., Bernstein I. D. Cd34+ marrow cells, devoid of t and b lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 1992; 80: 1693–1701
   PubMed Web of Science ®Google Scholar
• Terstappen L. W., Huang S., Safford M., Lansdorp P. M., Loken M. R. Sequential generations of hematopoietic colonies derived from single nonlineage-committed cd34+cd38-progenitor cells. Blood 1991; 77: 1218–1227
   PubMed Web of Science ®Google Scholar
• Hao Q. L., Shah A. J., Thiemann F. T., Smogorzewska E. M., Crooks G. M. A functional comparison of cd34+cd38-cells in cord blood and bone marrow. Blood 1995; 86: 3745–3753
   PubMed Web of Science ®Google Scholar
• Conneally E., Bardy P., Eaves C. J., Thomas T., Chappel S., Shpall E. J., Humphries R. K. Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer. Blood 1996; 87: 456–464
   PubMed Web of Science ®Google Scholar
• Gentry T., Smith C. Retroviral vector-mediated gene transfer into umbilical cord blood cd34brcd38-cd33-cells. Experimental Hematology 1999; 27: 1244–1254
   PubMed Web of Science ®Google Scholar
• McCowage G. B., Phillips K. L., Gentry T. L., Hull S., Kurtzberg J., Gilboa E., Smith C. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells. Experimental Hematology 1998; 26: 288–298
   PubMed Web of Science ®Google Scholar
• Dao M. A., Shah A. J., Crooks G. M., Nolta J. A. Engraftment and retroviral marking of cd34+ and cd34+cd38-human hematopoietic progenitors assessed in immune-deficient mice. Blood 1998; 91: 1243–1255
   PubMed Web of Science ®Google Scholar
• Ziegler B. L., Valtieri M., Porada G. A., De Maria R., Müller R., Masella B., Gabbianelli M., Casella I., Pelosi E., Bock T., Zanjani E. D., Peschle C. Kdr receptor: A key marker defining hematopoietic stem cells. Science 1999; 285: 1553–1558
   PubMed Web of Science ®Google Scholar
• Gallacher L., Murdoch B., Wu D. M., Karanu F. N., Keeney M., Bhatia M. Isolation and characterization of human cd34-lin-and cd34+lin-hematopoietic stem cells using cell surface markers ac133 and cd7. Blood 2000; 95: 2813–2820
   PubMed Web of Science ®Google Scholar
• Watt S. M., Bühring H. J., Rappold I., Chan J. Y., Lee-Prudhoe J., Jones T., Zannettino A. C., Simmons P. J., Doyonnas R., Sheer D., Butler L. H. Cd164, a novel sialomucin on cd34(+) and erythroid subsets, is located on human chromosome 6q21. Blood 1998; 92: 849–866
   PubMed Web of Science ®Google Scholar
• Yin A. H., Miraglia S., Zanjani E. D., Almeida-Porada G., Ogawa M., Leary A. G., Olweus J., Kearney J., Buck D. W. Ac133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002–5012
   PubMed Web of Science ®Google Scholar
• Goodell M. A., Rosenzweig M., Kim H., Marks D. F., DeMaria M., Paradis G., Grupp S. A., Sieff C. A., Mulligan R. C., Johnson R. P. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of cd34 antigen exist in multiple species. Nature Medicine 1997; 3: 1337–1345
   PubMed Web of Science ®Google Scholar
• Jones R. J., Barber J. P., Vala M. S., Collector M. I., Kaufmann S. H., Ludeman S. M., Colvin O. M., Hilton J. Assessment of aldehyde dehydrogenase in viable cells. Blood 1995; 85: 2742–2746
   PubMed Web of Science ®Google Scholar
• Jones R. J., Collector M. I., Barber J. P., Vala M. S., Fackler M. J., May W. S., Griffin C. A., Hawkins A. L., Zehnbauer B. A., Hilton J., Colvin O. M., Sharkis S. J. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood 1996; 88: 487–491
   PubMed Web of Science ®Google Scholar
• Storms R. W., Trujillo A. P., Springer J. B., Shah L., Colvin O. M., Ludeman S. M., Smith C. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 9118–9123
   PubMed Web of Science ®Google Scholar
• Morel F., Galy A., Chen B., Szilvassy S. J. Equal distribution of competitive long-term repopulating stem cells in the cd34+ and cd34-fractions of thy-1lowlin-/lowsca-1+ bone marrow cells. Experimental Hematology 1998; 26: 440–448
   PubMed Web of Science ®Google Scholar
• Zanjani E. D., Almeida-Porada G., Livingston A. G., Flake A. W., Ogawa M. Human bone marrow cd34-cells engraft in vivo and undergo multilineage expression that includes giving rise to cd34+ cells [see comments]. Experimental Hematology 1998; 26: 353–360
   PubMed Web of Science ®Google Scholar
• Bhatia M., Bonnet D., Murdoch B., Gan O. I., Dick J. E. A newly discovered class of human hematopoietic cells with scid-repopulating activity [see comments]. Nature Medicine 1998; 4: 1038–1045
   PubMed Web of Science ®Google Scholar
• Bhatia M., Wang J. C. Y., Kapp U., Bonnet D., Dick J. E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 5320–5325
   PubMed Web of Science ®Google Scholar
• Sato T., Laver J. H., Ogawa M. Reversible expression of cd34 by murine hematopoietic stem cells [see comments]. Blood 1999; 94: 2548–2554
   PubMed Web of Science ®Google Scholar
• Cheng J., Baumhueter S., Cacalano G., Carver-Moore K., Thibodeaux H., Thomas R., Broxmeyer H. E., Cooper S., Hague N., Moore M., Lasky L. A. Hematopoietic defects in mice lacking the sialomucin cd34. Blood 1996; 87: 479–490
   PubMed Web of Science ®Google Scholar
• Brandt J. E., Galy A. H., Luens K. M., Travis M., Young J., Tong J., Chen S., Davis T. A., Lee K. P., Chen B. P., Tushinski R., Hoffman R. Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line. Experimental Hematology 1998; 26: 950–961
   PubMed Web of Science ®Google Scholar
• Rebel V. I., Dragowska W., Eaves C. J., Humphries R. K., Lansdorp P. M. Amplification of sca-1+ linwga+ cells in serum-free cultures containing steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood 1994; 83: 128–136
   PubMed Web of Science ®Google Scholar
• Spangrude G. J., Brooks D. M., Tumas D. B. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 1995; 85: 1006–1016
   PubMed Web of Science ®Google Scholar
• Dorrell C., Gan O. I., Pereira D. S., Hawley R. G., Dick J. E. Expansion of human cord blood cd34+cd38-cells in ex vivo culture during retroviral transduction without a corresponding increase in scid repopulating cell (src) frequency: Dissociation of src phenotype and function. Blood 2000; 95: 102–110
   PubMed Web of Science ®Google Scholar
• Nilsson S., Dooner M. P. J. Q. Synchronized cell cycle induction of engrafting long term repopulating stem cells. Blood 1997; 90: 4646–4650
   PubMed Web of Science ®Google Scholar
• Peters S. O., Kittler E. L., Ramshaw H. S., Quesenberry P. J. Murine marrow cells expanded in culture with il-3, il-6, il-11, and scf acquire an engraftment defect in normal hosts [published erratum appears in exp hematol 1995 jun; 23(6): 568]. Experimental Hematology 1995; 23: 461–469
   PubMed Web of Science ®Google Scholar
• Traycoff C. M., Orazi A., Ladd A. C., Rice S., McMahel J., Srour E. F. Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded cd34+ cells. Experimental Hematology 1998; 26: 53–62
   PubMed Web of Science ®Google Scholar
• Gothot A., van der Loo J. C., Clapp D. W., Srour E. F. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood cd34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 2641–2649
   PubMed Web of Science ®Google Scholar
• Elwood N. J., Zogos H., Willson T., Begley C. G. Retroviral transduction of human progenitor cells: Use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by flt3/flk-2 ligand in vitro. Blood 1996; 88: 4452–4462
   PubMed Web of Science ®Google Scholar
• Dao M. A., Hannum C. H., Kohn D. B., Nolta J. A. Flt3 ligand preserves the ability of human cd34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood 1997; 89: 446–456
   PubMed Web of Science ®Google Scholar
• Haylock D. N., Horsfall M. J., Dowse T. L., Ramshaw H. S., Niutta S., Protopsaltis S., Peng L., Burrell C., Rappold I., Buhring H. J., Simmons P. J. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of flt3 ligand. Blood 1997; 90: 2260–2272
   PubMed Web of Science ®Google Scholar
• Shah A. J., Smogorzewska E. M., Hannum C., Crooks G. M. Flt3 ligand induces proliferation of quiescent human bone marrow cd34+cd38-cells and maintains progenitor cells in vitro. Blood 1996; 87: 3563–3570
   PubMed Web of Science ®Google Scholar
• Yu J., Soma T., Hanazono Y., Dunbar C. E. Abrogation of tgf-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency. Gene Therapy 1998; 5: 1265–1271
   PubMed Web of Science ®Google Scholar
• Dexter T. M., Allen T. D., Lajtha L. G. Conditions controlling the proliferation of haemopoietic stem cells in vitro. Journal Of Cellular Physiology 1977; 91: 335–344
   PubMed Web of Science ®Google Scholar
• Moore K. A., Deisseroth A. B., Reading C. L., Williams D. E., Belmont J. W. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 1992; 79: 1393–1399
   PubMed Web of Science ®Google Scholar
• Moscow J. A., Huang H., Carter C., Hines K., Zujewski J., Cusack G., Chow C., Venzon D., Sorrentino B., Chiang Y., Goldspiel B., Leitman S., Read E. J., Abati A., Gottesman M. M., Pastan I., Sellers S., Dunbar C., Cowan K. H. Engraftment of mdr1 and neor gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 1999; 94: 52–61
   PubMed Web of Science ®Google Scholar
• Gupta P., Oegema T. R. J., Brazil J. J., Dudek A. Z., Slungaard A., Verfaillie C. M. Human Itc-ic can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with o-sulfated heparan sulfates: Requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 2000; 95: 147–155
   PubMed Web of Science ®Google Scholar
• Simmons P. J., Levesque J. P., Zannettino A. C. Adhesion molecules in haemopoiesis. Baillieres Clinical Haematology 1997; 10: 485–505
   PubMed Web of Science ®Google Scholar
• Gupta P., McCarthy J. B., Verfaillie C. M. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood 1996; 87: 3229–3236
   PubMed Web of Science ®Google Scholar
• Lataillade J. -J., Clay D., Dupuy C., Rigal S., Jasmin C., Bourin P., Le Bousse-Kerdiles M. -C. Chemokine sdf-1 enhances circulating cd34+ cell proliferation in synergy with cytokines: Possible role in progenitor survival. Blood 2000; 95: 756–768
   PubMed Web of Science ®Google Scholar
• Shih C. -C., Hu M. C.-T., Hu J., Weng Y., Yazaki P. J., Medeiros J., Forman S. J. A secreted and lif-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells. Blood 2000; 95: 1957–1966
   PubMed Web of Science ®Google Scholar
• Yokota T., Oritani K., Mitsui H., Aoyama K., Ishikawa J., Sugahara H., Matsumura I., Tsai S., Tomiyama Y., Kanakura Y., Matsuzawa Y. Growth-supporting activities of fibronectin on hematopoietic stem/progenitor cells in vitro and in vivo: Structural requirement for fibronectin activities of cs1 and cell-binding domains. Blood 1998; 91: 3263–3272
   PubMed Web of Science ®Google Scholar
• Moritz T., Patel V. P., Williams D. A. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. Journal Of Clinical Investigation 1994; 93: 1451–1457
   PubMed Web of Science ®Google Scholar
• Traycoff C. M., Srour E. F., Dutt P., Fan Y., Cornetta K. The 30/35 kda chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors. Leukemia 1997; 11: 159–167
   PubMed Web of Science ®Google Scholar
• Murray L., Luens K., Tushinski R., Jin L., Burton M., Chen J., Forestell S., Hill B. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, flt3, and kit ligands and retronectin culture. Human Gene Therapy 1999; 10: 1743–1752
   PubMed Web of Science ®Google Scholar
• Dardalhon V., Noraz N., Pollok K., Rebouissou C., Boyer M., Bakker A. Q., Spits H., Taylor N. Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human t lymphocytes. Human Gene Therapy 1999; 10: 5–14
   PubMed Web of Science ®Google Scholar
• Dao M. A., Hashino K., Kato I., Nolta J. A. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood 1998; 92: 4612–4621
   PubMed Web of Science ®Google Scholar
• Moore K. A., Ema H., Lemischka I. R. In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood 1997; 89: 4337–4347
   PubMed Web of Science ®Google Scholar
• Carlesso N., Aster J. C., Sklar J., Scadden D. T. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 1999; 93: 838–848
   PubMed Web of Science ®Google Scholar
• Han W., Ye Q., Moore M. A. S. A soluble form of human delta-like-1 inhibits differentiation of hematopoietic progenitor cells. Blood 2000; 95: 1616–1625
   PubMed Web of Science ®Google Scholar
• Cheng T., Rodrigues N., Shen H., Yang Y., Dombrowski D., Sykes M., Scadden D. T. Hematopoietic stem cell quiescence is maintained by p21. Science 2000; 287: 1804–1808
   PubMed Web of Science ®Google Scholar
• Engelhardt M., Kumar R., Albanell J., Pettengell R., Han W., Moore M. A. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997; 90: 182–193
   PubMed Web of Science ®Google Scholar
• Nevins J. Towards an understanding of the functional complexity of the e2f and retinoblastoma families. Cell Growth and Differentiation 1998; 9: 585–593
   PubMedGoogle Scholar
• Roller M., Emerson S. G., Palsson B. O. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 1993; 82: 378–384
   PubMed Web of Science ®Google Scholar
• Emerson S. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics. Blood 1996; 87: 3082–3088
   PubMed Web of Science ®Google Scholar
• Purton L. E., Bernstein I. D., Collins S. J. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 2000; 95: 470–477
   PubMed Web of Science ®Google Scholar
• Bahnson A. B., Dunigan J. T., Baysal B. E., Mohney T., Atchison R. W., Nimgaonkar M. T., Ball E. D., Barranger J. A. Centrifugal enhancement of retroviral mediated gene transfer. Journal Of Virological Methods 1995; 54: 131–143
   PubMed Web of Science ®Google Scholar
• Bunnell B. A., Muul L. M., Donahue R. E., Blaese R. M., Morgan R. A. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 7739–7743
   PubMed Web of Science ®Google Scholar
• Crooks G. M., Kohn D. B. Growth factors increase amphotropic retrovirus binding to human cd34+ bone marrow progenitor cells. Blood 1993; 82: 3290–3297
   PubMed Web of Science ®Google Scholar
• Valera A., Perales J. C., Hatzoglou M., Bosch F. Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Human Gene Therapy 1994; 5: 449–456
   PubMed Web of Science ®Google Scholar
• Phillips K., Gentry T., McCowage G., Gilboa E., Smith C. Cell-surface markers for assessing gene transfer into human hematopoietic cells [see comments]. Nature Medicine 1996; 2: 1154–1156
   PubMed Web of Science ®Google Scholar
• Persons D. A., Allay J. A., Allay E. R., Smeyne R. J., Ashmun R. A., Sorrentino B. P., Nienhuis A. W. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 1997; 90: 1777–1786
   PubMed Web of Science ®Google Scholar
• Marx J. C., Allay J. A., Persons D. A., Nooner S. A., Hargrove P. W., Kelly P. F., Vanin E. F., Horwitz E. M. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells. Human Gene Therapy 1999; 10: 1163–1173
   PubMed Web of Science ®Google Scholar
• Verhasselt B., De Smedt M., Verhelst R., Naessens E., Plum J. Retrovirally transduced cd34++ human cord blood cells generate t cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood 1998; 91: 431–440
   PubMed Web of Science ®Google Scholar
• Hanazono Y., Yu J. M., Dunbar C. E., Emmons R. V. Green fluorescent protein retroviral vectors: Low titer and high recombination frequency suggest a selective disadvantage. Human Gene Therapy 1997; 8: 1313–1319
   PubMed Web of Science ®Google Scholar
• Siena S., Bregni M., Brando B., Ravagnani F., Bonadonna G., Gianni A. M. Circulation of cd34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905–1914
   PubMed Web of Science ®Google Scholar
• Sheridan W. P., Begley C. G., To L. B., Grigg A., Szer J., Maher D., Green M. D., Rowlings P. A., McGrath K. M., Cebon J., et al. Phase ii study of autologous filgrastim (g-csf)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies [published erratum appears in bone marrow transplant 1995 apr; 15(4): 654]. Bone Marrow Transplantation 1994; 14: 105–111
   PubMed Web of Science ®Google Scholar
• DeLuca E., Sheridan W. P., Watson D., Szer J., Begley C. G. Prior chemotherapy does not prevent effective mobilisation by g-csf of peripheral blood progenitor cells. British Journal Of Cancer 1992; 66: 893–899
   PubMed Web of Science ®Google Scholar
• Grigg A. P., Roberts A. W., Raunow H., Houghton S., Layton J. E., Boyd A. W., McGrath K. M., Maher D. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers [see comments]. Blood 1995; 86: 4437–4445
   PubMed Web of Science ®Google Scholar
• Socinski M. A., Cannistra S. A., Elias A., Antman K. H., Schnipper L., Griffin J. D. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988; 1: 1194–1198
   PubMed Web of Science ®Google Scholar
• Gianni A. M., Siena S., Bregni M., Tarella C., Stern A. C., Pileri A., Bonadonna G. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580–585
   PubMed Web of Science ®Google Scholar
• Villeval J. L., Dührsen U., Morstyn G., Metcalf D. Effect of recombinant human granulocyte-macrophage colony stimulating factor on progenitor cells in patients with advanced malignancies. British Journal Of Haematology 1990; 74: 36–44
   PubMed Web of Science ®Google Scholar
• Basser R. L., Rasko J. E., Clarke K., Cebon J., Green M. D., Grigg A. P., Zalcberg J., Cohen B., O'Byrne J., Menchaca D. M., Fox R. M., Begley C. G. Randomized, blinded, placebo-controlled phase i trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer [published erratum appears in blood 1997 sep 15; 90(6): 2513]. Blood 1997; 89: 3118–3128
   PubMed Web of Science ®Google Scholar
• Rasko J. E., Basser R. L., Boyd J., Mansfield R., O'Malley C. J., Hussein S., Berndt M. C., Clarke K., O'Byrne J., Sheridan W. P., Grigg A. P., Begley C. G. Multilineage mobilization of peripheral blood progenitor cells in humans following administration of peg-rhumgdf. British Journal Of Haematology 1997; 97: 871–880
   PubMed Web of Science ®Google Scholar
• Begley C. G., Basser R., Mansfield R., Thomson B., Parker W. R., Layton J., To B., Cebon J., Sheridan W. P., Fox R. M., Green M. D. Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans. Blood 1997; 90: 3378–3389
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T., Nakamoto B., Andrews R. G., Lyman S. D., Lee M. Y. In vivo effects of flt3/flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor. Blood 1997; 90: 620–629
   PubMed Web of Science ®Google Scholar
• Bodine D. M., Seidel N. E., Gale M. S., Nienhuis A. W., Orlic D. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994; 84: 1482–1491
   PubMed Web of Science ®Google Scholar
• Bregni M., Magni M., Siena S., Di Nicola M., Bonadonna G., Gianni A. M. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 1992; 80: 1418–1422
   PubMed Web of Science ®Google Scholar
• Cassel A., Cottier-Fox M., Doren S., Dunbar C. E. Retroviral-mediated gene transfer into cd34-enriched human peripheral blood stem cells. Experimental Hematology 1993; 21: 585–591
   PubMed Web of Science ®Google Scholar
• Lu M., Maruyama M., Zhang N., Levine F., Friedmann T., Ho A. D. High efficiency retroviral-mediated gene transduction into cd34+ cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor. Human Gene Therapy 1994; 5: 203–208
   PubMed Web of Science ®Google Scholar
• Bregni M., Di Nicola M., Siena S., Belli N., Milanesi M., Shammah S., Ravagnani F., Gianni A. M. Mobilized peripheral blood cd34+ cells express more amphotropic retrovirus receptor than bone marrow cd34+ cells. Haematologica 1998; 83: 204–208
   PubMedGoogle Scholar
• Gluckman E., Broxmeyer H. A., Auerbach A. D., Friedman H. S., Douglas G. W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P., et al. Hematopoietic reconstitution in a patient with fanconi's anemia by means of umbilical-cord blood from an hla-identical sibling. New England Journal Of Medicine 1989; 321: 1174–1178
   PubMed Web of Science ®Google Scholar
• Broxmeyer H. E., Gluckman E., Auerbach A., Douglas G. W., Friedman H., Cooper S., Hangoc G., Kurtzberg J., Bard J., Boyse E. A. Human umbilical cord blood: A clinically useful source of transplantable hematopoietic stem/progenitor cells. International Journal Of Cell Cloning 1990; 8(Suppl 1)76–89, discussion 89–91
   PubMedGoogle Scholar
• Wang J. C., Doedens M., Dick J. E. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo scid-repopulating cell assay. Blood 1997; 89: 3919–3924
   PubMed Web of Science ®Google Scholar
• Thierry D., Hervatin F., Traineau R., Brossard Y., Stark R., Benbunan M., Gluckman E. Hematopoietic progenitors cells in cord blood. Bone Marrow Transplantation 1992; 9(Suppl 1)101–104
   PubMedGoogle Scholar
• Traycoff C. M., Kosak S. T., Grigsby S., Srour E. F. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood 1995; 85: 2059–2068
   PubMed Web of Science ®Google Scholar
• Hows J. M., Bradley B. A., Marsh J. C., Luft T., Coutinho L., Testa N. G., Dexter T. M. Growth of human umbilical-cord blood in longterm haemopoietic cultures [see comments]. Lancet 1992; 340: 73–76
   PubMed Web of Science ®Google Scholar
• Medin J. A., Karlsson S. Selection of retrovirally transduced cells to enhance the efficiency of gene therapy. Proceedings Of The Association Of American Physicians 1997; 109: 111–119
   PubMedGoogle Scholar
• Bunting K. D., Galipeau J., Topham D., Benaim E., Sorrentino B. P. Transduction of murine bone marrow cells with an mdrl vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 1998; 92: 2269–2279
   PubMed Web of Science ®Google Scholar
• Deisseroth A. B., Pizzorno G. The use of chemotherapy resistance in cancer treatment. Cancer Journal From Scientific American 1997; 3: 60–69
   PubMed Web of Science ®Google Scholar
• Hanania E. G., Deisseroth A. B. Serial transplantation shows that early hematopoietic precursor cells are transduced by mdr-1 retroviral vector in a mouse gene therapy model. Cancer Gene Therapy 1994; 1: 21–25
   PubMed Web of Science ®Google Scholar
• Hanania E. G., Fu S., Roninson I., Zu Z., Deisseroth A. B. Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human mdr-1 transcription unit [see comments] [published erratum appears in gene ther 1995 aug; 2(6):433]. Gene Therapy 1995; 2: 279–284
   PubMed Web of Science ®Google Scholar
• Hegewisch-Becker S., Hanania E. G., Fu S., Körbling M., Deisseroth A. B., Andreeff M. Transduction of mdrl into human and mouse haemopoietic progenitor cells: Use of rhodamine (rh123) to determine transduction frequency and in vivo selection. British Journal Of Haematology 1995; 90: 876–883
   PubMed Web of Science ®Google Scholar
• O'Shaughnessy J. A., Cowan K. H., Nienhuis A. W., McDonagh K. T., Sorrentino B. P., Dunbar C. E., Chiang Y., Wilson W., Goldspiel B., Kohler D., et al. Retroviral mediated transfer of the human multidrug resistance gene (mdr-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Human Gene Therapy 1994; 5: 891–911
   PubMed Web of Science ®Google Scholar
• Havenga M., Valerio D., Hoogerbrugge P. M., Es H. In vivo methotrexate selection of murine hematopoietic cells transduced with a retroviral vector for gaucher's disease. Gene Therapy 1999; 6: 1661–1669
   PubMed Web of Science ®Google Scholar
• Patel D., Allay J., Belt J., Sorrentino B. Retroviral transfer of hent2 nucleoside transporter cdna confers broad spectrum anti-folate resistance in murine bone marrow cells. Blood 2000; 95: 2356–2363
   PubMed Web of Science ®Google Scholar
• Jin L., Siritanaratkul N., Emery D. W., Richard R. E., Kaushansky K., Papayannopoulou T., Blau C. A. Targeted expansion of genetically modified bone marrow cells. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 8093–8097
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., Gross F., Nusbaum P., Yvon E., Casanova J. L., Le Deist F., Fischer A. Correction of scid-x1 disease phenotype following γc gene transfer by a retroviral vector into cd34+ cells in two children. Science 1999; 288: 669–672
   Web of Science ®Google Scholar
• Kohn D. B., Hershfield M. S., Carbonaro D., Shigeoka A., Brooks J., Smogorzewska E. M., Barsky L. W., Chan R., Burotto F., Annett G., Nolta J. A., Crooks G., Kapoor N., Elder M., Wara D., Bowen T., Madsen E., Snyder F. F., Bastian J., Muul L., Blaese R. M., Weinberg K., Parkman R. T lymphocytes with a normal ada gene accumulate after transplantation of transduced autologous umbilical cord blood cd34+ cells in ada-deficient scid neonates. Nature Medicine 1998; 4: 775–780
   PubMed Web of Science ®Google Scholar
• Quesenberry P. J., Ramshaw H., Crittenden R. B., Stewart F. M., Rao S., Peters S., Becker P., Lowry P., Blomberg M., Reilly J., et al. Engraftment of normal murine marrow into nonmyeloablated host mice. Blood Cells 1994; 20: 348–350
   PubMedGoogle Scholar
• Rao S. S., Peters S. O., Crittenden R. B., Stewart F. M., Ramshaw H. S., Quesenberry P. J. Stem cell transplantation in the normal nonmyeloablated host: Relationship between cell dose, schedule, and engraftment. Experimental Hematology 1997; 25: 114–121
   PubMed Web of Science ®Google Scholar
• Stewart F. M., Crittenden R. B., Lowry P. A., Pearson-White S., Quesenberry P. J. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice [see comments]. Blood 1993; 81: 2566–2571
   PubMed Web of Science ®Google Scholar
• Tisdale J. F., Hanazono Y., Sellers S. E., Agricola B. A., Metzger M. E., Donahue R. E., Dunbar C. E. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 1998; 92: 1131–1141
   PubMed Web of Science ®Google Scholar